First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 925, Issue , 2013, Pages 1-9

  Serralheiro, Ana ^a,b   Alves, Gilberto ^b,c   Fortuna, Ana ^a,b   Rocha, Marília ^b,d   Falcão, Amílcar ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Antiepileptic drugs; Bioanalytical method validation; High performance liquid chromatography; Human plasma; Therapeutic drug monitoring

Indexed keywords

ANTIEPILEPTIC DRUGS; BIOANALYTICAL METHODS; CARBAMAZEPINE 10 ,11 EPOXIDES; CHROMATOGRAPHIC SEPARATIONS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS; HUMAN PLASMAS; SIMULTANEOUS DETERMINATIONS; THERAPEUTIC DRUG MONITORING;

CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOL; PATIENT MONITORING; PLASMA (HUMAN);

AMIDES;

10,11 DIHYDRO 10,11 DIHYDROXYCARBAMAZEPINE; ACETONITRILE; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; DRUG METABOLITE; KETOPROFEN; LAMOTRIGINE; LICARBAZEPINE; METHANOL; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TRIETHYLAMINE; WATER;

ACCURACY; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION;

ANTICONVULSANTS; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; DRUG STABILITY; HUMANS; LIMIT OF DETECTION; LINEAR MODELS; PHENOBARBITAL; PHENYTOIN; REPRODUCIBILITY OF RESULTS; TRIAZINES;

EID: 84875242875     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.02.026     Document Type: Article

References (35)

1. Bialer M., White H.S. Nat. Rev. Drug Discov. 2010, 9:68.
2. Gerlach A.C., Krajewski J.L. Pharmaceuticals 2010, 3:2884.
3. Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Chadwick D., Guerreiro C., Kalviainen R., Mattson R., Perucca E., Tomson T. Epilepsia 2006, 47:1094.
4. Patsalos P.N., Berry D.J., Bourgeois B.F.D., Cloyd J.C., Glauser T.A., Johannessen S.I., Leppik I.E., Tomson T., Perucca E. Epilepsia 2008, 49:1239.
5. Garnett W.R., St Louis E.K., Henry T.R., Bramley T. Curr. Neuropharmacol. 2009, 7:83.
6. St Louis E.K. Curr. Neuropharmacol. 2009, 7:96.
7. St Louis E.K. Pharmaceuticals 2010, 3:2956.
8. Krasowski M.D. Pharmaceuticals 2010, 3:1909.
9. Landmark C.J., Rytter E., Johannessen S.I. Seizure 2007, 16:356.
10. Ma C., Jiao Z., Jie Y., Shi X. Chromatographia 2007, 65:267.
11. Vermeij T.A.C., Edelbroek P.M. J. Chromatogr. B 2007, 15:40.
12. Paglia G., D'Apolito O., Garofalo D., Scarano C., Corso G. J. Chromatogr. B 2007, 860:153.
13. Greiner-Sosanko E., Lower D.R., Virji M.A., Krasowski M.D. Biomed. Chromatogr. 2007, 21:225.
14. Mandrioli R., Ghedini N., Albani F., Kenndler E., Raggi M.A. J. Chromatogr. B 2003, 783:253.
15. Queiroz R.H., Bertucci C., Malfará W.R., Dreossi S.A., Chaves A.R., Valério D.A., Queiroz M.E. J. Pharm. Biomed. Anal. 2008, 48:428.
16. Khoschsorur G.A., Frühwirth F., Halwachs-Baumann G. Chromatographia 2001, 54:345.
17. Franceschi L., Furlanut M. Pharmacol. Res. 2005, 51:297.
18. Bugamelli F., Sabbioni C., Mandrioli R., Kenndler E., Albani F., Raggi M.A. Anal. Chim. Acta 2002, 472:1.
19. Budakova L., Brozmanova H., Grundmann M., Fischer J. J. Sep. Sci. 2008, 31:1.
20. Levert H., Odou P., Robert H. Biomed. Chromatogr. 2002, 16:19.
21. Patil K.M., Boghankar S.L. J. Pharm. Biomed. Anal. 2005, 39:181.
22. Bhatti M.M., Hanson G.D., Schultz L. J. Pharm. Biomed. Anal. 1998, 16:1233.
23. Fortuna A., Sousa J., Alves G., Falcão A., Soares-da-Silva P. Anal. Bioanal. Chem. 2010, 397:1605.
24. Subramanian M., Birnbaum A.K., Remmel R.P. Ther. Drug Monit. 2008, 30:347.
25. Heideloff C., Bunch D.R., Wang S. Ther. Drug Monit. 2010, 32:102.
26. Shibata M., Hashi S., Nakanishi H., Masuda S., Katsura T., Yano I. Biomed. Chromatogr. 2012, 12:1519.
27. US Food and Drug Administration, Guidance for Industry:Bioanalytical method validation.; 2001. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
28. European Medicines Agency, Guideline on bioanalytical method validation.; 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
29. Almeida A.M., Castel-Branco M.M., Falcão A.C. J. Chromatogr. B 2002, 774:215.
30. Sousa J., Alves G., Abrantes J., Fortuna A., Falcão A. Anal. Bioanal. Chem. 2012, 403:93.
31. Kim K.B., Seo K.A., Kim S.E., Bae S.K., Kim D.H., Shin J.G. J. Pharm. Biomed. Anal. 2011, 56:771.
32. Maurer H.H., Kratzsch C., Weber A.A., Peters F.T., Kraemer T. J. Mass Spectrom. 2002, 37:687.
33. Juergens U. J. Chromatogr. B 1984, 310:97.
34. Alves G., Figueiredo I., Castel-Branco M., Loureiro A., Fortuna A., Falcão A., Caramona M. Biomed. Chromatogr. 2007, 21:1127.
35. Kimiskidis V., Spanakis M., Niopas I., Kazis D., Gabrieli C., Kanaze F.I., Divanoglou D. J. Pharm. Biomed. Anal. 2007, 43:763.